Beta Bionics, Inc.

NasdaqGM:BBNX Stock Report

Market Cap: US$479.3m

Beta Bionics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:BBNX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Dec 25SellUS$41,862Stephen FeiderIndividual1,427US$29.34
02 Dec 25SellUS$96,163Sean SaintIndividual3,278US$29.34
02 Dec 25SellUS$31,184Mike MensingerIndividual1,063US$29.34
02 Dec 25SellUS$25,112Mark HopmanIndividual856US$29.34
02 Sep 25SellUS$27,578Stephen FeiderIndividual1,462US$18.86
02 Sep 25SellUS$20,542Mike MensingerIndividual1,089US$18.86
02 Sep 25SellUS$15,996Mark HopmanIndividual848US$18.86
02 Sep 25SellUS$19,146Steven RussellIndividual1,015US$18.86
02 Sep 25SellUS$63,361Sean SaintIndividual3,359US$18.86
02 Jun 25SellUS$26,783Stephen FeiderIndividual1,497US$18.69
02 Jun 25SellUS$61,526Sean SaintIndividual3,439US$18.69
02 Jun 25SellUS$15,529Mark HopmanIndividual868US$18.69
02 Jun 25SellUS$18,588Steven RussellIndividual1,039US$18.69
02 Jun 25SellUS$19,948Mike MensingerIndividual1,115US$18.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BBNX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,714,5323.18%
Private Companies3,277,2206.07%
VC/PE Firms3,570,1136.62%
Hedge Funds11,638,50821.6%
Institutions33,747,52062.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 100.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.3%
Eventide Asset Management, LLC
4,994,728US$53.9m0.76%0.85%
9.72%
Farallon Capital Management, L.L.C.
4,313,920US$46.6m0%0.28%
8.04%
Sands Capital Alternatives, LLC
3,570,113US$38.6m0%8.93%
7.74%
Morgan Stanley
3,436,182US$37.1m-8.11%no data
7.38%
Zone Healthcare Holdings, LLC
3,277,220US$35.4m0%no data
6.57%
BlackRock, Inc.
2,913,920US$31.5m4.77%no data
5.71%
Soleus Capital Management, L.P.
2,534,565US$27.4m-34.5%1.16%
5.63%
RTW Investments, LP
2,500,000US$27.0m-24.2%0.3%
5.16%
Point72 Asset Management, L.P.
2,290,023US$24.7m132%0.04%
5%
The Vanguard Group, Inc.
2,218,238US$24.0m0.09%no data
2.99%
Healthcare of Ontario Pension Plan Trust Fund
1,327,100US$14.3m0%0.02%
2.97%
Omega Fund Management, LLC
1,316,183US$14.2m-31.5%7.1%
2.29%
Firas El-Khatib
1,015,228US$11.0m0%no data
2.16%
Driehaus Capital Management LLC
956,784US$10.3m-9.65%0.05%
2.13%
Millennium Management LLC
945,461US$10.2m18.6%0.01%
2.11%
Deerfield Management Company, L.P.
938,308US$10.1m-19.7%0.14%
2.08%
Geode Capital Management, LLC
921,464US$10.0m0.43%no data
1.94%
State Street Global Advisors, Inc.
863,133US$9.3m4.46%no data
1.53%
Eversept Partners, L.P.
678,262US$7.3m0%0.44%
1.46%
Walleye Capital LLC
646,539US$7.0m9.36%0.03%
1.36%
Perceptive Advisors LLC
602,944US$6.5m117%0.12%
1.35%
Vestal Point Capital, LP
600,000US$6.5m0%0.22%
1.3%
12 West Capital Management LP
575,000US$6.2m0%0.74%
1.2%
T. Rowe Price Group, Inc.
532,749US$5.8m9.25%no data
0.97%
Lord, Abbett & Co. LLC
430,403US$4.6m18.1%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/20 01:31
End of Day Share Price 2026/03/20 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Beta Bionics, Inc. is covered by 16 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Travis SteedBofA Global Research
Travis SteedBofA Global Research